Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines
Delivery carriers are a critical component in the development of mRNA vaccines. Here, we describe the synthesis of a cationic polymer as a carrier for mRNA cancer vaccine delivery. In vivo results show that this polymer-based mRNA vaccine significantly delays tumor growth after vaccination of mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743697/

Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccine-CEJ 2023 Jan
Related Content
AACR 2026 Posters | Sneak Peek The Annual Meeting of the American Association for Cancer Research (AACR) will be held...
VIEW RESOURCEAt AACR 2026, scientists from our WuXi Biology platform will present a collection of the company’s latest oncology research findings...
VIEW RESOURCE
